"Nonsmall cell lung cancer" trang 1 - tải miễn phí từ tailieunhanh
The effects of PIKfyve inhibitor YM201636 on claudins and malignancy potential of nonsmall cell cancer cells

The effects of PIKfyve inhibitor YM201636 on claudins and malignancy potential of nonsmall cell cancer cells
9    62    1
Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with nonsmall cell lung cancer

Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with nonsmall cell lung cancer
9    34    1
Comparison of the efficacies of firstgeneration epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced nonsmall-cell lung cancer harboring EGFR mutations

Comparison of the efficacies of firstgeneration epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced nonsmall-cell lung cancer harboring EGFR mutations
7    84    0
The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced nonsmall cell lung cancer: A systematic review and meta-analysis

The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced nonsmall cell lung cancer: A systematic review and meta-analysis
17    41    1
SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in nonsmall cell lung cancer patients

SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in nonsmall cell lung cancer patients
10    74    0
LncRNA SNHG10 is downregulated in nonsmall cell lung cancer and predicts poor survival

LncRNA SNHG10 is downregulated in nonsmall cell lung cancer and predicts poor survival
6    56    1
Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced nonsmall cell lung cancer: A meta-analysis

Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced nonsmall cell lung cancer: A meta-analysis
16    106    0
Clinicopathological variables influencing overall survival, recurrence and postrecurrence survival in resected stage I nonsmall-cell lung cancer

Clinicopathological variables influencing overall survival, recurrence and postrecurrence survival in resected stage I nonsmall-cell lung cancer
10    74    0
Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced nonsmall cell lung cancer patients with poor performance status

Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced nonsmall cell lung cancer patients with poor performance status
8    67    1
Re-challenging immune checkpoint inhibitor in a patient with advanced nonsmall cell lung cancer: A case report

Re-challenging immune checkpoint inhibitor in a patient with advanced nonsmall cell lung cancer: A case report
4    51    1
RNA-based analysis of ALK fusions in nonsmall cell lung cancer cases showing IHC/ FISH discordance

RNA-based analysis of ALK fusions in nonsmall cell lung cancer cases showing IHC/ FISH discordance
9    42    1
Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected nonsmall cell lung cancer

Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected nonsmall cell lung cancer
13    49    1
Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous nonsmall cell lung cancer in elderly patients: TORG1015

Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous nonsmall cell lung cancer in elderly patients: TORG1015
7    51    1
Prognostic analysis of patients with nonsmall cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases

Prognostic analysis of patients with nonsmall cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases
10    36    1
Clinical impact of tetracyclines and/ or proton pump inhibitors on the efficacy of epidermal growth factor receptor inhibitors in non-small cell lung cancer: A retrospective cohort study

Clinical impact of tetracyclines and/ or proton pump inhibitors on the efficacy of epidermal growth factor receptor inhibitors in non-small cell lung cancer: A retrospective cohort study
12    4    1
A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage nonsmall cell lung cancer

A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage nonsmall cell lung cancer
10    82    1
Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated nonsmall-cell lung cancer

Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated nonsmall-cell lung cancer
8    56    0
Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer

Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer
13    26    1
An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitornaïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations

An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitornaïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations
11    33    1
Wilms’ tumour gene 1 (WT1) enhances nonsmall cell lung cancer malignancy and is inhibited by microRNA-498-5p

Wilms’ tumour gene 1 (WT1) enhances nonsmall cell lung cancer malignancy and is inhibited by microRNA-498-5p
15    1    1